HomeCompareCDMO vs JEPQ

CDMO vs JEPQ: Dividend Comparison 2026

CDMO yields 16.01% · JEPQ yields 11.47%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JEPQ wins by $23.2K in total portfolio value
10 years
CDMO
CDMO
● Live price
16.01%
Share price
$12.49
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.6K
Annual income
$1.79
Full CDMO calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.47%
Share price
$53.77
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.8K
Annual income
$2,269.18
Full JEPQ calculator →

Portfolio growth — CDMO vs JEPQ

📍 JEPQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCDMOJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CDMO + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CDMO pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CDMO
Annual income on $10K today (after 15% tax)
$1,361.09/yr
After 10yr DRIP, annual income (after tax)
$1.52/yr
JEPQ
Annual income on $10K today (after 15% tax)
$974.55/yr
After 10yr DRIP, annual income (after tax)
$1,928.80/yr
At 15% tax rate, JEPQ beats the other by $1,927.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CDMO + JEPQ for your $10,000?

CDMO: 50%JEPQ: 50%
100% JEPQ50/50100% CDMO
Portfolio after 10yr
$34.2K
Annual income
$1,135.49/yr
Blended yield
3.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CDMO right now

CDMO
Analyst Ratings
1
Strong
8
Buy
1
Hold
Consensus: Buy
Price Target
$8.00
-35.9% upside vs current
Range: $8.00 — $8.00
Altman Z
-0.6
Piotroski
3/9
JEPQ
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CDMO buys
0
JEPQ buys
0
No recent congressional trades found for CDMO or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCDMOJEPQ
Forward yield16.01%11.47%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%0%
Portfolio after 10y$22.6K$45.8K
Annual income after 10y$1.79$2,269.18
Total dividends collected$1.7K$17.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: CDMO vs JEPQ ($10,000, DRIP)

YearCDMO PortfolioCDMO Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$11,501$800.64$11,967$1,146.53$466.00JEPQ
2$12,736$430.27$14,216$1,268.02$1.5KJEPQ
3$13,850$222.66$16,774$1,392.20$2.9KJEPQ
4$14,933$113.15$19,667$1,518.21$4.7KJEPQ
5$16,035$57.01$22,925$1,645.21$6.9KJEPQ
6$17,186$28.60$26,578$1,772.40$9.4KJEPQ
7$18,404$14.33$30,656$1,899.04$12.3KJEPQ
8$19,699$7.17$35,194$2,024.45$15.5KJEPQ
9$21,081$3.59$40,228$2,148.01$19.1KJEPQ
10$22,559$1.79$45,796$2,269.18$23.2KJEPQ

CDMO vs JEPQ: Complete Analysis 2026

CDMOStock

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

Full CDMO Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this CDMO vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CDMO vs SCHDCDMO vs JEPICDMO vs OCDMO vs KOCDMO vs MAINCDMO vs XYLDCDMO vs QYLDCDMO vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.